Baxalta: Shire shares slip as sales miss estimates in first full quarter with Baxalta
Shire has billed its thirdquarter results as recordbreaking but markets are less convinced as the
Read full article »
CEO
Baxalta is developing, manufacturing and commercializing therapies for orphan diseases.
Read more